已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Pilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease

医学 随机对照试验 梅德林 物理疗法 预先护理计划 外科 护理部 缓和医疗 法学 政治学
作者
Nneka N. Ufere,B. Robinson,John Donlan,Teresa Indriolo,Judith Bloom,Abigail Scherrer,Nancy M. Mason,Arpan Patel,Jennifer C. Lai,Raymond T. Chung,Angelo E. Volandes,Areej El‐Jawahri
出处
期刊:Clinical Gastroenterology and Hepatology [Elsevier]
卷期号:20 (10): 2287-2295.e3 被引量:17
标识
DOI:10.1016/j.cgh.2021.10.027
摘要

Transplant-ineligible patients with advanced liver disease rarely receive timely advance care planning (ACP). Tools are needed to educate these patients about medical interventions available at the end of life to promote ACP.This single-site pilot randomized controlled trial assessed the feasibility, acceptability, and preliminary efficacy of an ACP video decision support tool for improving transplant-ineligible advanced liver disease patients' knowledge about and preferences for end-of-life care. Intervention participants watched a 5-minute video depicting 3 levels of goals of care: life-prolonging care (cardiopulmonary resuscitation [CPR] and intubation), life-limiting care (hospitalization, no CPR/intubation), and comfort care. Control subjects received only a verbal narrative of these 3 levels of goals of care. The primary outcome was feasibility (≥60% enrollment rate). Secondary outcomes included acceptability of the video, patients' knowledge of end-of-life care options (6-item test; range, 0-6), and postintervention goals-of-care and CPR or intubation preferences.We enrolled 85% (n = 50 of 59) of eligible patients randomized to the video (n = 26) or verbal (n = 24) arm. In the video arm, 81% of patients reported being very comfortable watching the video. Patients in the video arm had higher mean knowledge scores (5.7 vs 4.8; P < .001) and were less likely to prefer to receive CPR compared with patients in the verbal arm (35% vs 63%; P = .09).An ACP video decision support tool to improve knowledge about and preferences for end-of-life care is both feasible and highly acceptable to transplant-ineligible patients with advanced liver disease with a high enrollment rate and promising preliminary efficacy. Future studies should examine the efficacy of the ACP video for enhancing the quality of their end-of-life care. (ClinicalTrials.gov, Number: NCT03557086).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11111111112发布了新的文献求助10
刚刚
安静幻枫应助WEIXING采纳,获得50
2秒前
wangy完成签到 ,获得积分10
2秒前
王大壮完成签到,获得积分10
3秒前
mayday完成签到,获得积分10
5秒前
所所应助MMay采纳,获得10
5秒前
小巧冬易完成签到,获得积分10
6秒前
这种发布了新的文献求助10
7秒前
ljy阿完成签到 ,获得积分10
10秒前
小巧冬易发布了新的文献求助10
12秒前
英俊的铭应助jovrtic采纳,获得10
13秒前
SciGPT应助甜甜谷雪采纳,获得10
14秒前
marongzhi完成签到 ,获得积分10
16秒前
ccc完成签到 ,获得积分10
19秒前
cult发布了新的文献求助10
19秒前
飞鸟发布了新的文献求助10
23秒前
24秒前
qx关闭了qx文献求助
25秒前
扶摇完成签到 ,获得积分10
28秒前
着急的电脑完成签到,获得积分10
28秒前
斯文败类应助微信研友采纳,获得10
30秒前
30秒前
火山发布了新的文献求助30
30秒前
32秒前
33秒前
35秒前
欧大大发布了新的文献求助10
36秒前
唐云炳完成签到 ,获得积分10
36秒前
何小熊发布了新的文献求助10
37秒前
hh发布了新的文献求助30
41秒前
星辰大海应助端庄镜子采纳,获得10
47秒前
48秒前
hh完成签到,获得积分10
49秒前
微信研友发布了新的文献求助10
52秒前
53秒前
斯文败类应助11111111112采纳,获得10
54秒前
55秒前
leo0531完成签到,获得积分10
56秒前
56秒前
嗯哼应助科研通管家采纳,获得20
56秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
How Maoism Was Made: Reconstructing China, 1949-1965 800
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 600
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
Shining Light on the Dark Side of Personality 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3310963
求助须知:如何正确求助?哪些是违规求助? 2943728
关于积分的说明 8516304
捐赠科研通 2619056
什么是DOI,文献DOI怎么找? 1431863
科研通“疑难数据库(出版商)”最低求助积分说明 664484
邀请新用户注册赠送积分活动 649755